3HL-31821-82566
4 vaccinations
9 coded responses
52 check-ins
8 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Survey response — day 0, dose 2MedDRA: Muscle tightness, Ocular discomfort — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: Muscle tightness in my neck. Pressure felt behind my eyes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-07-26
- 2021-10-23
-
2021-11-19
Dose 3 — Pfizer-BioNTech
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Laryngitis, Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Laryngitis and severe head cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-23
Call successfulDoes not wish to fill out VAERS report
- 2022-05-20
-
2022-11-19
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID 19MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-09
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2022-12-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-12-11
-
2022-12-12
Survey response — days 1–6 daily, dose 4MedDRA: Increased upper airway secretion, Nasal congestion, Rhinorrhoea — Feeling: GoodFree text: Runny / stuffy nose along with mucus in throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Survey response — days 1–6 daily, dose 4MedDRA: Headache, Nasal congestion, Rhinorrhoea — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: A very intense headache that started yesterday late morning and has not gone away. The intensity has increased a lot today. Continuing runny and stuffy nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Headache, Increased upper airway secretion, Rhinorrhoea, Secretion discharge — Feeling: Fair · Headache, Fatigue or tirednessFree text: Continuing cough, runny nose and mucus in back of throat. Headache is less severe than yesterday but is still present.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-15
Survey response — days 1–6 daily, dose 4MedDRA: Increased upper airway secretion, Nasal congestion — Feeling: Fair · Fatigue or tirednessFree text: Continuation of stuffy nose and mucus in back of throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Survey response — day 7, dose 4MedDRA: Cough, Nasal congestion — Feeling: Good · HeadacheFree text: Continuing stuffy nose, slight coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-23
- 2022-12-30
- 2023-01-06
- 2023-01-13
- 2023-01-20
-
2023-03-10
Survey response — 3 months, dose 4MedDRA: Lower respiratory tract infection, Malaise, Office visit, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-10
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
| 4 | 2022-12-09 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Muscle tightness in my neck. Pressure felt behind my eyes.
Release 11 — 3 months, dose 3
Symptoms: Laryngitis and severe head cold.
Release 12 — 12 months, dose 3
Symptoms: COVID 19
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Runny / stuffy nose along with mucus in throat.
Systemic reaction (other): A very intense headache that started yesterday late morning and has not gone away. The intensity has increased a lot today. Continuing runny and stuffy nose.
Systemic reaction (other): Continuing cough, runny nose and mucus in back of throat. Headache is less severe than yesterday but is still present.
Systemic reaction (other): Continuation of stuffy nose and mucus in back of throat.
Release 12 — day 7, dose 4
Systemic reaction (other): Continuing stuffy nose, slight cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Lower respiratory tract infection | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Increased upper airway secretion | · | · | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Secretion discharge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release